{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:55:21Z","timestamp":1787961321370,"version":"build-2784847793"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11274-025-04656-5","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:38:49Z","timestamp":1761737929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut bacteria-derived metabolites and their implications in mental health and neurological diseases"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-9858","authenticated-orcid":false,"given":"Rajnish","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-1414","authenticated-orcid":false,"given":"Mandeep Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"4656_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS12030430","volume":"12","author":"ME Abouelela","year":"2024","unstructured":"Abouelela ME, Helmy YA (2024) Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives. Microorganisms 12:430. https:\/\/doi.org\/10.3390\/MICROORGANISMS12030430","journal-title":"Microorganisms"},{"key":"4656_CR2","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.CHEMREV.2C00431","volume":"123","author":"N Aggarwal","year":"2022","unstructured":"Aggarwal N, Kitano S, Puah GRY et al (2022) Microbiome and human health: current understanding, engineering, and enabling technologies. Chem Rev 123:31. https:\/\/doi.org\/10.1021\/ACS.CHEMREV.2C00431","journal-title":"Chem Rev"},{"key":"4656_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43045-024-00395-9","volume":"31","author":"GK Ahmed","year":"2024","unstructured":"Ahmed GK, Ramadan HK-A, Elbeh K, Haridy NA (2024) Bridging the gap: associations between gut microbiota and psychiatric disorders. Middle East Curr Psychiatry 31:2. https:\/\/doi.org\/10.1186\/s43045-024-00395-9","journal-title":"Middle East Curr Psychiatry"},{"key":"4656_CR4","doi-asserted-by":"publisher","first-page":"229544","DOI":"10.3389\/FNAGI.2016.00256\/BIBTEX","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Kakhaki RD et al (2016) Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer\u2019s disease: A randomized, double-blind and controlled trial. Front Aging Neurosci 8:229544. https:\/\/doi.org\/10.3389\/FNAGI.2016.00256\/BIBTEX","journal-title":"Front Aging Neurosci"},{"key":"4656_CR5","doi-asserted-by":"publisher","unstructured":"AL-Ishaq RK, Samuel SM, B\u00fcsselberg D (2023) The influence of gut microbial species on diabetes mellitus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24098118","DOI":"10.3390\/ijms24098118"},{"key":"4656_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX10111644","author":"S Ali","year":"2021","unstructured":"Ali S, Corbi G, Maes M et al (2021) Exploring the impact of flavonoids on symptoms of depression: a systematic review and meta-analysis. Antioxidants. https:\/\/doi.org\/10.3390\/ANTIOX10111644","journal-title":"Antioxidants"},{"key":"4656_CR7","doi-asserted-by":"publisher","first-page":"1411168","DOI":"10.3389\/FPHAR.2024.1411168\/BIBTEX","volume":"15","author":"A Alizadeh","year":"2024","unstructured":"Alizadeh A, Pourfallah-Taft Y, Khoshnazar M et al (2024) Flavonoids against depression: a comprehensive review of literature. Front Pharmacol 15:1411168. https:\/\/doi.org\/10.3389\/FPHAR.2024.1411168\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"4656_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/J.GASTRE.2021.01.002","volume":"44","author":"J \u00c1lvarez","year":"2021","unstructured":"\u00c1lvarez J, Fern\u00e1ndez Real JM, Guarner F et al (2021) Gut microbes and health. Gastroenterolog\u00eda y Hepatolog\u00eda. (English Edition) 44:519\u2013535. https:\/\/doi.org\/10.1016\/J.GASTRE.2021.01.002","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda. (English Edition)"},{"key":"4656_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep43522","author":"R Aoki","year":"2017","unstructured":"Aoki R, Kamikado K, Suda W et al (2017) A proliferative probiotic bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Sci Rep. https:\/\/doi.org\/10.1038\/srep43522","journal-title":"Sci Rep"},{"key":"4656_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E34092","volume":"10","author":"S Ashique","year":"2024","unstructured":"Ashique S, Mohanto S, Ahmed MG et al (2024) Gut-brain axis: a cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 10:e34092. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E34092","journal-title":"Heliyon"},{"key":"4656_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21239234","volume":"21","author":"OV Averina","year":"2020","unstructured":"Averina OV, Zorkina YA, Yunes RA et al (2020) Bacterial metabolites of human gut microbiota correlating with depression. Int J Mol Sci 21:9234. https:\/\/doi.org\/10.3390\/IJMS21239234","journal-title":"Int J Mol Sci"},{"key":"4656_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2297864","volume":"16","author":"T Aziz","year":"2024","unstructured":"Aziz T, Hussain N, Hameed Z, Lin L (2024) Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Gut Microbes 16:2297864. https:\/\/doi.org\/10.1080\/19490976.2023.2297864","journal-title":"Gut Microbes"},{"key":"4656_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.12.003","author":"BS Beresford-Jones","year":"2022","unstructured":"Beresford-Jones BS, Forster SC, Stares MD et al (2022) The mouse gastrointestinal bacteria catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe. https:\/\/doi.org\/10.1016\/j.chom.2021.12.003","journal-title":"Cell Host Microbe"},{"key":"4656_CR14","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/PNAS.1918095117","volume":"117","author":"AP Bhatt","year":"2020","unstructured":"Bhatt AP, Pellock SJ, Biernat KA et al (2020) Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A 117:7374\u20137381. https:\/\/doi.org\/10.1073\/PNAS.1918095117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4656_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/13623613221082710","volume":"27","author":"L Billeci","year":"2023","unstructured":"Billeci L, Callara AL, Guiducci L et al (2023) A randomized controlled trial into the effects of probiotics on electroencephalography in preschoolers with autism. Autism 27:117\u2013132. https:\/\/doi.org\/10.1177\/13623613221082710","journal-title":"Autism"},{"key":"4656_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-4939-0897-4_17","volume":"817","author":"YE Borre","year":"2014","unstructured":"Borre YE, Moloney RD, Clarke G et al (2014) The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol 817:373\u2013403. https:\/\/doi.org\/10.1007\/978-1-4939-0897-4_17","journal-title":"Adv Exp Med Biol"},{"key":"4656_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1178646920928984\/ASSET\/IMAGES\/LARGE\/10.1177_1178646920928984-FIG3.JPEG","author":"A Bosi","year":"2020","unstructured":"Bosi A, Banfi D, Bistoletti M et al (2020) Tryptophan metabolites along the Microbiota-Gut-Brain axis: an interkingdom communication system influencing the gut in health and disease. Int J Tryptophan Res. https:\/\/doi.org\/10.1177\/1178646920928984\/ASSET\/IMAGES\/LARGE\/10.1177_1178646920928984-FIG3.JPEG. 13:","journal-title":"Int J Tryptophan Res"},{"key":"4656_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102563","volume":"71","author":"A Bruggeman","year":"2024","unstructured":"Bruggeman A, Vandendriessche C, Hamerlinck H et al (2024) Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial. EClin Med 71:102563. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102563","journal-title":"EClin Med"},{"key":"4656_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/NU11112805","volume":"11","author":"S Bull-Larsen","year":"2019","unstructured":"Bull-Larsen S, Hasan Mohajeri M (2019) The potential influence of the bacterial microbiome on the development and progression of ADHD. Nutrients 11:2805. https:\/\/doi.org\/10.3390\/NU11112805","journal-title":"Nutrients"},{"key":"4656_CR21","doi-asserted-by":"publisher","unstructured":"Camberos-Barraza J, Guadr\u00f3n-Llanos AM, la Herr\u00e1n-Arita AKD (2024) The Gut Microbiome-Neuroglia Axis: Implications for Brain Health, Inflammation, and Disease. Neuroglia 5:254\u2013273. https:\/\/doi.org\/10.3390\/NEUROGLIA5030018","DOI":"10.3390\/NEUROGLIA5030018"},{"key":"4656_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03454-y","volume":"22","author":"Q Cao","year":"2025","unstructured":"Cao Q, Shen M, Li R et al (2025) Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway. J Neuroinflammation 22:133. https:\/\/doi.org\/10.1186\/s12974-025-03454-y","journal-title":"J Neuroinflammation"},{"key":"4656_CR23","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals Gastroenterol\u202f: Q Publication Hellenic Soc Gastroenterol 28:203","journal-title":"Annals Gastroenterol : Q Publication Hellenic Soc Gastroenterol"},{"key":"4656_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/J.COPH.2019.08.001","volume":"48","author":"G Caspani","year":"2019","unstructured":"Caspani G, Swann J (2019) Small talk: microbial metabolites involved in the signaling from microbiota to brain. Curr Opin Pharmacol 48:99\u2013106. https:\/\/doi.org\/10.1016\/J.COPH.2019.08.001","journal-title":"Curr Opin Pharmacol"},{"key":"4656_CR25","doi-asserted-by":"publisher","first-page":"1158198","DOI":"10.3389\/FCHEM.2023.1158198\/BIBTEX","volume":"11","author":"P Chaudhary","year":"2023","unstructured":"Chaudhary P, Janmeda P, Docea AO et al (2023) Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Front Chem 11:1158198. https:\/\/doi.org\/10.3389\/FCHEM.2023.1158198\/BIBTEX","journal-title":"Front Chem"},{"key":"4656_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/NU13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients 13:2099. https:\/\/doi.org\/10.3390\/NU13062099","journal-title":"Nutrients"},{"key":"4656_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.12.009","author":"L Cheng","year":"2024","unstructured":"Cheng L, Wu H, Cai X et al (2024) A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behavior. Cell Host Microbe. https:\/\/doi.org\/10.1016\/j.chom.2023.12.009","journal-title":"Cell Host Microbe"},{"key":"4656_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/NRGASTRO.2014.40","volume":"11","author":"SM Collins","year":"2014","unstructured":"Collins SM (2014) A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 11:497\u2013505. https:\/\/doi.org\/10.1038\/NRGASTRO.2014.40","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4656_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ECCO-JCC\/JJAA143","volume":"15","author":"F Crouwel","year":"2020","unstructured":"Crouwel F, Buiter HJC, De Boer NK (2020) Gut microbiota-driven drug metabolism in inflammatory bowel disease. J Crohns Colitis 15:307. https:\/\/doi.org\/10.1093\/ECCO-JCC\/JJAA143","journal-title":"J Crohns Colitis"},{"key":"4656_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tim.2021.01.003","volume":"29","author":"M Cunningham","year":"2021","unstructured":"Cunningham M, Azcarate-Peril MA, Barnard A et al (2021) Shaping the future of probiotics and prebiotics. Trends Microbiol 29:667\u2013685. https:\/\/doi.org\/10.1016\/j.tim.2021.01.003","journal-title":"Trends Microbiol"},{"key":"4656_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16:461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4656_CR33","doi-asserted-by":"publisher","unstructured":"Das TK, Ganesh BP (2023) Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer\u2019s disease progression. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2023.2206504","DOI":"10.1080\/19490976.2023.2206504"},{"key":"4656_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YCO.0000000000000117","volume":"28","author":"S Dash","year":"2015","unstructured":"Dash S, Clarke G, Berk M, Jacka FN (2015) The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 28:1\u20136. https:\/\/doi.org\/10.1097\/YCO.0000000000000117","journal-title":"Curr Opin Psychiatry"},{"key":"4656_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/02648725.2021.1989847","volume":"37","author":"N Debnath","year":"2021","unstructured":"Debnath N, Kumar R, Kumar A et al (2021) Gut-microbiota derived bioactive metabolites and their functions in host physiology. Biotechnol Genet Eng Rev 37:105\u2013153. https:\/\/doi.org\/10.1080\/02648725.2021.1989847","journal-title":"Biotechnol Genet Eng Rev"},{"key":"4656_CR36","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0727","volume":"15","author":"W Deng","year":"2024","unstructured":"Deng W, Yi P, Xiong Y et al (2024) Gut metabolites acting on the gut-brain axis: regulating the functional state of microglia. Aging Dis 15:480. https:\/\/doi.org\/10.14336\/AD.2023.0727","journal-title":"Aging Dis"},{"key":"4656_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.BBI.2016.12.010","volume":"62","author":"F Dickerson","year":"2017","unstructured":"Dickerson F, Severance E, Yolken R (2017) The microbiome, immunity, and schizophrenia and bipolar disorder. Brain Behav Immun 62:46\u201352. https:\/\/doi.org\/10.1016\/J.BBI.2016.12.010","journal-title":"Brain Behav Immun"},{"key":"4656_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.NEUROSCIENCE.2018.01.060","volume":"374","author":"C Doenyas","year":"2018","unstructured":"Doenyas C (2018) Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder. Neuroscience 374:271\u2013286. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2018.01.060","journal-title":"Neuroscience"},{"key":"4656_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JCMGH.2024.01.024","volume":"18","author":"TS Dong","year":"2024","unstructured":"Dong TS, Mayer E (2024) Advances in brain\u2013gut\u2013microbiome interactions: a comprehensive update on signaling mechanisms, disorders, and therapeutic implications. Cell Mol Gastroenterol Hepatol 18:1\u201313. https:\/\/doi.org\/10.1016\/J.JCMGH.2024.01.024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4656_CR40","doi-asserted-by":"publisher","unstructured":"Dong S, Sun M, He C, Cheng H (2022) Brain-gut-microbiota axis in Parkinson\u2019s disease: a historical review and future perspective. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.015","DOI":"10.1016\/j.brainresbull.2022.02.015"},{"key":"4656_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/LIFE14050559","volume":"14","author":"S Facchin","year":"2024","unstructured":"Facchin S, Bertin L, Bonazzi E et al (2024) Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. Life 14:559. https:\/\/doi.org\/10.3390\/LIFE14050559","journal-title":"Life"},{"key":"4656_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01355-5","author":"Y Fan","year":"2023","unstructured":"Fan Y, St\u00f8ving RK, Berreira Ibraim S et al (2023) The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice. Nat Microbiol. https:\/\/doi.org\/10.1038\/s41564-023-01355-5","journal-title":"Nat Microbiol"},{"key":"4656_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/NU11030521","volume":"11","author":"A Fattorusso","year":"2019","unstructured":"Fattorusso A, Di Genova L, Dell\u2019isola GB et al (2019) Autism spectrum disorders and the gut microbiota. Nutrients 11:521. https:\/\/doi.org\/10.3390\/NU11030521","journal-title":"Nutrients"},{"key":"4656_CR44","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665114001463","author":"HJ Flint","year":"2015","unstructured":"Flint HJ, Duncan SH, Scott KP, Louis P (2015) Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. https:\/\/doi.org\/10.1017\/S0029665114001463","journal-title":"Proc Nutr Soc"},{"key":"4656_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS12040657","volume":"12","author":"E Fock","year":"2023","unstructured":"Fock E, Parnova R (2023) Mechanisms of blood\u2013brain barrier protection by microbiota-derived short-chain fatty acids. Cells 12:657. https:\/\/doi.org\/10.3390\/CELLS12040657","journal-title":"Cells"},{"key":"4656_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/S00406-014-0502-Z","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond G, Loundou A, Hamdani N et al (2014) Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 264:651\u2013660. https:\/\/doi.org\/10.1007\/S00406-014-0502-Z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4656_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305\u2013312. https:\/\/doi.org\/10.1016\/j.tins.2013.01.005","journal-title":"Trends Neurosci"},{"key":"4656_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS242115915","volume":"24","author":"V Fuochi","year":"2023","unstructured":"Fuochi V, Furneri PM (2023) Applications of probiotics and their potential health benefits. Int J Mol Sci 24:15915. https:\/\/doi.org\/10.3390\/IJMS242115915","journal-title":"Int J Mol Sci"},{"key":"4656_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/NU15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M et al (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15:2211. https:\/\/doi.org\/10.3390\/NU15092211","journal-title":"Nutrients"},{"key":"4656_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ADVANCES\/NMZ127","volume":"11","author":"K Gao","year":"2019","unstructured":"Gao K, Mu CL, Farzi A, Zhu WY (2019) Tryptophan metabolism: A link between the gut microbiota and brain. Adv Nutr 11:709. https:\/\/doi.org\/10.1093\/ADVANCES\/NMZ127","journal-title":"Adv Nutr"},{"key":"4656_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu C, Farzi A, Zhu W (2020) Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr 11:709\u2013723. https:\/\/doi.org\/10.1093\/advances\/nmz127","journal-title":"Adv Nutr"},{"key":"4656_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/NU10060708","author":"S Gerhardt","year":"2018","unstructured":"Gerhardt S, Mohajeri MH (2018) Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases. Nutrients. https:\/\/doi.org\/10.3390\/NU10060708","journal-title":"Nutrients"},{"key":"4656_CR53","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neubiorev.2019.12.011","volume":"108","author":"B Golofast","year":"2020","unstructured":"Golofast B, Vales K (2020) The connection between microbiome and schizophrenia. Neurosci Biobehav Rev 108:712\u2013731. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.12.011","journal-title":"Neurosci Biobehav Rev"},{"key":"4656_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/NU15153454","volume":"15","author":"I Grabska-Koby\u0142ecka","year":"2023","unstructured":"Grabska-Koby\u0142ecka I, Szpakowski P, Kr\u00f3l A et al (2023) Polyphenols and their impact on the prevention of neurodegenerative diseases and development. Nutrients 15:3454. https:\/\/doi.org\/10.3390\/NU15153454","journal-title":"Nutrients"},{"key":"4656_CR55","doi-asserted-by":"publisher","first-page":"1222089","DOI":"10.3389\/FRMBI.2023.1222089\/BIBTEX","volume":"2","author":"R Gudka","year":"2023","unstructured":"Gudka R, Nyinoh IW (2023) Fecal microbial transplantation as a novel therapeutic for autism spectrum disorders: a review of the current literature. Front Microbiomes 2:1222089. https:\/\/doi.org\/10.3389\/FRMBI.2023.1222089\/BIBTEX","journal-title":"Front Microbiomes"},{"key":"4656_CR56","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1080\/10408398.2014.903384","volume":"56","author":"K Gul","year":"2016","unstructured":"Gul K, Singh AK, Jabeen R (2016) Nutraceuticals and functional foods: the foods for the future world. Crit Rev Food Sci Nutr 56:2617\u20132627. https:\/\/doi.org\/10.1080\/10408398.2014.903384","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4656_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/APT.17049","volume":"56","author":"EL Gulliver","year":"2022","unstructured":"Gulliver EL, Young RB, Chonwerawong M et al (2022) Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther 56:192. https:\/\/doi.org\/10.1111\/APT.17049","journal-title":"Aliment Pharmacol Ther"},{"key":"4656_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00516-9","author":"X Guo","year":"2023","unstructured":"Guo X, Li C, Zhang J et al (2023) Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut\u2013brain axis. Nat Aging. https:\/\/doi.org\/10.1038\/s43587-023-00516-9","journal-title":"Nat Aging"},{"key":"4656_CR182","doi-asserted-by":"publisher","unstructured":"Gupta MK, Chauhan K, Bhardwaj S, Srivastava R. Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment. Probiotics Antimicrob Proteins. Published online June 27, 2025. https:\/\/doi.org\/10.1007\/s12602-025-10632-0","DOI":"10.1007\/s12602-025-10632-0"},{"key":"4656_CR181","doi-asserted-by":"publisher","unstructured":"Gupta MK, Srivastava R (2025) Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management. Probiotics Antimicrob Proteins 17(4):2629\u20132652 https:\/\/doi.org\/10.1007\/s12602-025-10582-7","DOI":"10.1007\/s12602-025-10582-7"},{"key":"4656_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.05.009","author":"L Guthrie","year":"2019","unstructured":"Guthrie L, Kelly L (2019) Bringing microbiome-drug interaction research into the clinic. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.009","journal-title":"EBioMedicine"},{"key":"4656_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40168-021-01101-1\/FIGURES\/5","volume":"9","author":"DV Guzior","year":"2021","unstructured":"Guzior DV, Quinn RA (2021) Review: microbial transformations of human bile acids. Microbiome 9:1\u201313. https:\/\/doi.org\/10.1186\/S40168-021-01101-1\/FIGURES\/5","journal-title":"Microbiome"},{"issue":"8","key":"4656_CR61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/10408444.2024.2362985","volume":"54","author":"M Hellwig","year":"2024","unstructured":"Hellwig M, Diel P, Eisenbrand G et al (2024) Dietary glycation compounds \u2013 implications for human health. Crit Rev Toxicol 54(8):485\u2013617. https:\/\/doi.org\/10.1080\/10408444.2024.2362985","journal-title":"Crit Rev Toxicol"},{"key":"4656_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-60984-6","author":"H Horiuchi","year":"2020","unstructured":"Horiuchi H, Kamikado K, Aoki R et al (2020) Bifidobacterium animalis subsp. Lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-020-60984-6","journal-title":"Sci Rep"},{"key":"4656_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030578","author":"T Hrncir","year":"2022","unstructured":"Hrncir T (2022) Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10030578","journal-title":"Microorganisms"},{"key":"4656_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1456793","author":"C-Y Hsu","year":"2024","unstructured":"Hsu C-Y, Khachatryan LG, Younis NK et al (2024) Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1456793","journal-title":"Front Microbiol"},{"key":"4656_CR65","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/J.BBI.2012.05.010","volume":"26","author":"MM Hughes","year":"2012","unstructured":"Hughes MM, Carballedo A, McLoughlin DM et al (2012) Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain Behav Immun 26:979\u2013987. https:\/\/doi.org\/10.1016\/J.BBI.2012.05.010","journal-title":"Brain Behav Immun"},{"key":"4656_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/NU8010056","volume":"8","author":"TA Jenkins","year":"2016","unstructured":"Jenkins TA, Nguyen JCD, Polglaze KE, Bertrand PP (2016) Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients 8:56. https:\/\/doi.org\/10.3390\/NU8010056","journal-title":"Nutrients"},{"key":"4656_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/NU15010151\/S1","volume":"15","author":"H Jiang","year":"2023","unstructured":"Jiang H, Chen C, Gao J (2023) Extensive summary of the important roles of Indole propionic Acid, a gut microbial metabolite in host health and disease. Nutrients 15:151. https:\/\/doi.org\/10.3390\/NU15010151\/S1","journal-title":"Nutrients"},{"key":"4656_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01755-7","author":"J Jiang","year":"2024","unstructured":"Jiang J, Wang D, Jiang Y et al (2024) The gut metabolite indole-3-propionic acid activates ERK1 to restore social function and hippocampal inhibitory synaptic transmission in a 16p11.2 microdeletion mouse model. Microbiome. https:\/\/doi.org\/10.1186\/s40168-024-01755-7","journal-title":"Microbiome"},{"key":"4656_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/NU15204391","volume":"15","author":"S Ju","year":"2023","unstructured":"Ju S, Shin Y, Han S et al (2023) The gut\u2013brain axis in schizophrenia: the implications of the gut microbiome and SCFA production. Nutrients 15:4391. https:\/\/doi.org\/10.3390\/NU15204391","journal-title":"Nutrients"},{"key":"4656_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081305","volume":"17","author":"AE Kalkan","year":"2025","unstructured":"Kalkan AE, BinMowyna MN, Raposo A et al (2025) Beyond the gut: unveiling butyrate\u2019s global health impact through gut health and dysbiosis-related conditions: a narrative review. Nutrients 17:1305. https:\/\/doi.org\/10.3390\/nu17081305","journal-title":"Nutrients"},{"key":"4656_CR71","doi-asserted-by":"publisher","DOI":"10.5402\/2013\/481651","author":"M Kechagia","year":"2013","unstructured":"Kechagia M, Basoulis D, Konstantopoulou S et al (2013) Health benefits of probiotics: a review. ISRN Nutrition. https:\/\/doi.org\/10.5402\/2013\/481651","journal-title":"ISRN Nutrition"},{"key":"4656_CR72","doi-asserted-by":"publisher","first-page":"100136","DOI":"10.1016\/J.ADVNUT.2023.10.008","volume":"15","author":"CS Kim","year":"2023","unstructured":"Kim CS (2023) Roles of Diet-Associated gut microbial metabolites on brain health: Cell-to-Cell interactions between gut bacteria and the central nervous system. Adv Nutr 15:100136. https:\/\/doi.org\/10.1016\/J.ADVNUT.2023.10.008","journal-title":"Adv Nutr"},{"key":"4656_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2023.122311","volume":"336","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Chatterjee A (2024a) Noxious ramifications of cosmetic pollutants on gastrointestinal microbiome: a pathway to neurological disorders. Life Sci 336:122311. https:\/\/doi.org\/10.1016\/J.LFS.2023.122311","journal-title":"Life Sci"},{"key":"4656_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/J.AQUATOX.2024.106902","volume":"270","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Chatterjee A (2024b) Zebrafish: a trending model for gut-brain axis investigation. Aquat Toxicol 270:106902. https:\/\/doi.org\/10.1016\/J.AQUATOX.2024.106902","journal-title":"Aquat Toxicol"},{"key":"4656_CR75","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1021\/ACSPTSCI.4C00008","volume":"7","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Maheshwari R et al (2024c) Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies. ACS Pharmacol Transl Sci 7:967\u2013990. https:\/\/doi.org\/10.1021\/ACSPTSCI.4C00008","journal-title":"ACS Pharmacol Transl Sci"},{"key":"4656_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S13205-024-03946-3","volume":"14","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Singh S, Prajapati BG (2024d) Revisiting microbial exopolysaccharides: a biocompatible and sustainable polymeric material for multifaceted biomedical applications. 3 Biotech 14:1\u201324. https:\/\/doi.org\/10.1007\/S13205-024-03946-3","journal-title":"3 Biotech"},{"key":"4656_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S12032-025-02761-X\/METRICS","volume":"42","author":"NS Kiran","year":"2025","unstructured":"Kiran NS, Chatterjee A, Yashaswini C et al (2025a) The Gastrointestinal mycobiome in inflammation and cancer: unraveling fungal dysbiosis, pathogenesis, and therapeutic potential. Med Oncol 42:1\u201318. https:\/\/doi.org\/10.1007\/S12032-025-02761-X\/METRICS","journal-title":"Med Oncol"},{"key":"4656_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S12032-025-02972-2\/METRICS","volume":"42","author":"NS Kiran","year":"2025","unstructured":"Kiran NS, Yashaswini C, Chatterjee A, Prajapati B (2025b) Impact of Gastrointestinal dysbiosis on Tryptophan metabolism and neurological cancer progression. Med Oncol 42:1\u201330. https:\/\/doi.org\/10.1007\/S12032-025-02972-2\/METRICS","journal-title":"Med Oncol"},{"key":"4656_CR79","doi-asserted-by":"publisher","unstructured":"Kiriyama Y, Nochi H (2023) Role of microbiota-modified bile acids in the regulation of intracellular organelles and neurodegenerative diseases. Genes 14:825. https:\/\/doi.org\/10.3390\/GENES14040825","DOI":"10.3390\/GENES14040825"},{"key":"4656_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2021.782082","author":"EM Klann","year":"2022","unstructured":"Klann EM, Dissanayake U, Gurrala A et al (2022) The gut-brain axis and its relation to parkinson\u2019s disease: a review. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/FNAGI.2021.782082","journal-title":"Front Aging Neurosci"},{"key":"4656_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23031222","author":"P Konopelski","year":"2022","unstructured":"Konopelski P, Mogilnicka I (2022) Biological effects of Indole-3-propionic acid, a gut microbiota-derived metabolite, and its precursor Tryptophan in mammals\u2019 health and disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23031222","journal-title":"Int J Mol Sci"},{"key":"4656_CR82","doi-asserted-by":"publisher","first-page":"e33953","DOI":"10.7554\/ELIFE.33953","volume":"7","author":"N Koppel","year":"2018","unstructured":"Koppel N, Bisanz JE, Pandelia ME et al (2018) Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. Elife 7:e33953. https:\/\/doi.org\/10.7554\/ELIFE.33953","journal-title":"Elife"},{"key":"4656_CR83","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5056\/JNM18087","volume":"25","author":"K Kowalski","year":"2019","unstructured":"Kowalski K, Mulak A (2019) Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil 25:48\u201360. https:\/\/doi.org\/10.5056\/JNM18087","journal-title":"J Neurogastroenterol Motil"},{"key":"4656_CR84","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/BS.IRN.2016.09.001","volume":"131","author":"AD Kraneveld","year":"2016","unstructured":"Kraneveld AD, Szklany K, de Theije CGM, Garssen J (2016) Gut-to-Brain axis in autism spectrum disorders: central role for the Microbiome. Int Rev Neurobiol 131:263\u2013287. https:\/\/doi.org\/10.1016\/BS.IRN.2016.09.001","journal-title":"Int Rev Neurobiol"},{"key":"4656_CR85","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1194\/JLR.R088989","volume":"60","author":"A Kriaa","year":"2018","unstructured":"Kriaa A, Bourgin M, Potiron A et al (2018) Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res 60:323. https:\/\/doi.org\/10.1194\/JLR.R088989","journal-title":"J Lipid Res"},{"key":"4656_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.669638","volume":"12","author":"E K\u00fcpeli Akkol","year":"2021","unstructured":"K\u00fcpeli Akkol E, Tatl\u0131 \u00c7ankaya I, \u015eeker Karatoprak G et al (2021) Natural compounds as medical strategies in the prevention and treatment of psychiatric disorders seen in neurological diseases. Front Pharmacol 12:669638. https:\/\/doi.org\/10.3389\/FPHAR.2021.669638","journal-title":"Front Pharmacol"},{"issue":"9","key":"4656_CR87","doi-asserted-by":"publisher","first-page":"Page1449","DOI":"10.3390\/BIOMEDICINES9101449","volume":"2021","author":"JW Lee","year":"2021","unstructured":"Lee JW, Chun W, Lee HJ et al (2021) The role of microglia in the development of neurodegenerative diseases. Biomedicines 2021(9):Page1449\u201391449. https:\/\/doi.org\/10.3390\/BIOMEDICINES9101449","journal-title":"Biomedicines"},{"key":"4656_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/J.NEURON.2012.09.013","volume":"76","author":"KP Lesch","year":"2012","unstructured":"Lesch KP, Waider J (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76:175\u2013191. https:\/\/doi.org\/10.1016\/J.NEURON.2012.09.013","journal-title":"Neuron"},{"key":"4656_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2017.00120","author":"Q Li","year":"2017","unstructured":"Li Q, Han Y, Dy ABC, Hagerman RJ (2017) The gut microbiota and autism spectrum disorders. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/FNCEL.2017.00120","journal-title":"Front Cell Neurosci"},{"key":"4656_CR90","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s11010-023-04853-6","volume":"479","author":"S Li","year":"2024","unstructured":"Li S, Zhao L, Xiao J et al (2024) The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances. Mol Cell Biochem 479:2217\u20132243. https:\/\/doi.org\/10.1007\/s11010-023-04853-6","journal-title":"Mol Cell Biochem"},{"key":"4656_CR91","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/S00115-020-01029-1","volume":"91","author":"JM Lima-Ojeda","year":"2020","unstructured":"Lima-Ojeda JM, Rupprecht R, Baghai TC (2020) [Gut microbiota and depression : pathophysiology of depression: hypothalamic-pituitary-adrenal axis and microbiota-gut-brain axis]. Nervenarzt 91:1108\u20131114. https:\/\/doi.org\/10.1007\/S00115-020-01029-1","journal-title":"Nervenarzt"},{"key":"4656_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/J.MAD.2021.111560","author":"S Liu","year":"2021","unstructured":"Liu S, Gao J, Liu K, Zhang HL (2021) Microbiota-gut-brain axis and Alzheimer\u2019s disease: implications of the blood-brain barrier as an intervention target. Mech Ageing Dev. https:\/\/doi.org\/10.1016\/J.MAD.2021.111560","journal-title":"Mech Ageing Dev"},{"key":"4656_CR93","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.0104","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Tan Y, Cheng H et al (2022) Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis 13:1106. https:\/\/doi.org\/10.14336\/AD.2022.0104","journal-title":"Aging Dis"},{"key":"4656_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS et al (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9:1\u201353. https:\/\/doi.org\/10.1038\/S41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"key":"4656_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis P, Flint HJ (2017) Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 19:29\u201341. https:\/\/doi.org\/10.1111\/1462-2920.13589","journal-title":"Environ Microbiol"},{"key":"4656_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/J.COBEHA.2019.01.011","volume":"28","author":"A Madison","year":"2019","unstructured":"Madison A, Kiecolt-Glaser JK (2019) Stress, depression, diet, and the gut microbiota: human\u2013bacteria interactions at the core of psychoneuroimmunology and nutrition. Curr Opin Behav Sci 28:105. https:\/\/doi.org\/10.1016\/J.COBEHA.2019.01.011","journal-title":"Curr Opin Behav Sci"},{"key":"4656_CR97","doi-asserted-by":"crossref","unstructured":"Maftei NM, Raileanu CR, Balta AA et al (2024) The potential impact of probiotics on human health: An update on their health-promoting properties. Microorganisms 12","DOI":"10.3390\/microorganisms12020234"},{"key":"4656_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2025.123392","volume":"363","author":"K Mallick","year":"2025","unstructured":"Mallick K, Islam SR, Krishna V et al (2025a) Role of AIM2 and cGAS-STING signaling in high fat high carbohydrate diet-induced gut dysbiosis associated neurodegeneration. Life Sci 363:123392. https:\/\/doi.org\/10.1016\/J.LFS.2025.123392","journal-title":"Life Sci"},{"key":"4656_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.JPSYCHIRES.2025.02.031","volume":"184","author":"K Mallick","year":"2025","unstructured":"Mallick K, Khodve G, Ruwatia R, Banerjee S (2025b) Gut microbes: therapeutic target for neuropsychiatric disorders. J Psychiatr Res 184:27\u201338. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2025.02.031","journal-title":"J Psychiatr Res"},{"key":"4656_CR100","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000150","volume":"25","author":"LL Mazaleuskaya","year":"2015","unstructured":"Mazaleuskaya LL, Sangkuhl K, Thorn CF et al (2015) PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics 25:416. https:\/\/doi.org\/10.1097\/FPC.0000000000000150","journal-title":"Pharmacogenet Genomics"},{"key":"4656_CR101","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/FBE2.12081","volume":"3","author":"AK Meher","year":"2024","unstructured":"Meher AK, Acharya B, Sahu PK (2024) Probiotics: bridging the interplay of a healthy gut and psychoneurological well-being. Food Bioengineering 3:126\u2013147. https:\/\/doi.org\/10.1002\/FBE2.12081","journal-title":"Food Bioengineering"},{"key":"4656_CR102","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/S00415-021-10567-W","volume":"269","author":"V Metta","year":"2022","unstructured":"Metta V, Leta V, Mrudula KR et al (2022) Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol 269:1154\u20131163. https:\/\/doi.org\/10.1007\/S00415-021-10567-W","journal-title":"J Neurol"},{"key":"4656_CR103","doi-asserted-by":"publisher","first-page":"1098412","DOI":"10.3389\/FMICB.2023.1098412\/BIBTEX","volume":"14","author":"S Miri","year":"2023","unstructured":"Miri S, Yeo JD, Abubaker S, Hammami R (2023) Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? Front Microbiol 14:1098412. https:\/\/doi.org\/10.3389\/FMICB.2023.1098412\/BIBTEX","journal-title":"Front Microbiol"},{"key":"4656_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2021.112352","volume":"145","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Dehkhodaie E, Bouzari B et al (2022) Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed Pharmacother 145:112352. https:\/\/doi.org\/10.1016\/J.BIOPHA.2021.112352","journal-title":"Biomed Pharmacother"},{"issue":"S1","key":"4656_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00394-018-1703-4","volume":"57","author":"MH Mohajeri","year":"2018","unstructured":"Mohajeri MH, Brummer RJM, Rastall RA et al (2018) The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr 57(S1):1\u201314. https:\/\/doi.org\/10.1007\/S00394-018-1703-4","journal-title":"Eur J Nutr"},{"key":"4656_CR106","doi-asserted-by":"publisher","first-page":"15094","DOI":"10.3390\/IJMS242015094","volume":"24","author":"A Moianu","year":"2023","unstructured":"Moianu A, \u0218erban G, Andone S (2023) The role of Short-Chain fatty acids in Microbiota\u2013Gut\u2013Brain Cross-Talk with a focus on amyotrophic lateral sclerosis: A systematic review. Int J Mol Sci 24:15094. https:\/\/doi.org\/10.3390\/IJMS242015094","journal-title":"Int J Mol Sci"},{"key":"4656_CR107","volume-title":"The Microbiota-Gut-Brain axis: Tryptophan metabolism and potential therapeutic strategies","author":"A Mora-Navarro","year":"2024","unstructured":"Mora-Navarro A, Mora-Mart\u00ednez MM, Pati\u00f1o-Laguna JDJ A, et al (2024) The Microbiota-Gut-Brain axis: Tryptophan metabolism and potential therapeutic strategies. In: Weight Loss - A Multidisciplinary Perspective, IntechOpen"},{"key":"4656_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13050674","author":"S Mousa","year":"2023","unstructured":"Mousa S, Sarfraz M, Mousa WK (2023) The interplay between gut microbiota and oral medications and its impact on advancing precision medicine. Metabolites. https:\/\/doi.org\/10.3390\/metabo13050674","journal-title":"Metabolites"},{"key":"4656_CR109","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210608","volume":"84","author":"A Mulak","year":"2021","unstructured":"Mulak A (2021) Bile acids as key modulators of the Brain-Gut-Microbiota axis in Alzheimer\u2019s disease. J Alzheimers Dis 84:461. https:\/\/doi.org\/10.3233\/JAD-210608","journal-title":"J Alzheimers Dis"},{"key":"4656_CR110","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/WJG.V21.I37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in parkinson\u2019s disease. World J Gastroenterol 21:10609. https:\/\/doi.org\/10.3748\/WJG.V21.I37.10609","journal-title":"World J Gastroenterol"},{"key":"4656_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22147671","volume":"22","author":"N Munawar","year":"2021","unstructured":"Munawar N, Ahsan K, Muhammad K et al (2021) Hidden role of gut microbiome dysbiosis in schizophrenia: antipsychotics or psychobiotics as therapeutics? Int J Mol Sci 22:7671. https:\/\/doi.org\/10.3390\/IJMS22147671","journal-title":"Int J Mol Sci"},{"key":"4656_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33160\/YAM.2024.02.001","volume":"67","author":"K Nakaso","year":"2024","unstructured":"Nakaso K (2024) Roles of microglia in neurodegenerative diseases. Yonago Acta Med 67:1. https:\/\/doi.org\/10.33160\/YAM.2024.02.001","journal-title":"Yonago Acta Med"},{"key":"4656_CR113","doi-asserted-by":"publisher","unstructured":"Nakhal MM, Yassin LK, Alyaqoubi R et al (2024) The microbiota\u2013gut\u2013brain axis and neurological disorders: A comprehensive review. Life 14:1234. https:\/\/doi.org\/10.3390\/LIFE14101234","DOI":"10.3390\/LIFE14101234"},{"key":"4656_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-024-54769-4","volume":"14","author":"EI Nayman","year":"2024","unstructured":"Nayman EI, Schwartz BA, Polmann M et al (2024) Differences in gut microbiota between Dutch and South-Asian Surinamese: potential implications for type 2 diabetes mellitus. Sci Rep 14:1\u201314. https:\/\/doi.org\/10.1038\/S41598-024-54769-4","journal-title":"Sci Rep"},{"key":"4656_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHARMTHERA.2022.108119","author":"G Nehra","year":"2022","unstructured":"Nehra G, Bauer B, Hartz AMS (2022) Blood-brain barrier leakage in Alzheimer\u2019s disease: from discovery to clinical relevance. Pharmacol Ther. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2022.108119","journal-title":"Pharmacol Ther"},{"key":"4656_CR116","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.2010-2825","author":"S Ozonoff","year":"2011","unstructured":"Ozonoff S, Young GS, Carter A et al (2011) Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics. https:\/\/doi.org\/10.1542\/PEDS.2010-2825","journal-title":"Pediatrics"},{"key":"4656_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01689-6","author":"C Pan","year":"2023","unstructured":"Pan C, Zhang H, Zhang L et al (2023) Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide. Microbiome. https:\/\/doi.org\/10.1186\/s40168-023-01689-6","journal-title":"Microbiome"},{"key":"4656_CR118","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/J.NEUINT.2015.07.003","volume":"89","author":"MD Pandareesh","year":"2015","unstructured":"Pandareesh MD, Mythri RB, Srinivas Bharath MM (2015) Bioavailability of dietary polyphenols: factors contributing to their clinical application in CNS diseases. Neurochem Int 89:198\u2013208. https:\/\/doi.org\/10.1016\/J.NEUINT.2015.07.003","journal-title":"Neurochem Int"},{"key":"4656_CR119","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/FIMMU.2019.01486","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G et al (2019) Corrigendum: short chain fatty acids (SCFAs)-Mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:1486. https:\/\/doi.org\/10.3389\/FIMMU.2019.01486","journal-title":"Front Immunol"},{"key":"4656_CR120","doi-asserted-by":"publisher","unstructured":"Patrono E, Svoboda J, Stuchl\u00edk A (2021) Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis. Behav Brain Funct 17:1\u201321. https:\/\/doi.org\/10.1186\/S12993-021-00180-2","DOI":"10.1186\/S12993-021-00180-2"},{"key":"4656_CR121","doi-asserted-by":"publisher","unstructured":"Peralta-Marzal LN, Rojas-Velazquez D, Rigters D et al (2024) A robust microbiome signature for autism spectrum disorder across different studies using machine learning. Sci Rep 1 14:1\u201311. https:\/\/doi.org\/10.1038\/s41598-023-50601-7","DOI":"10.1038\/s41598-023-50601-7"},{"key":"4656_CR122","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M et al (2017) Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017:8416763. https:\/\/doi.org\/10.1155\/2017\/8416763","journal-title":"Oxid Med Cell Longev"},{"key":"4656_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS8020199","author":"V Prakash Reddy","year":"2020","unstructured":"Prakash Reddy V, Aryal P, Robinson S et al (2020) Polyphenols in Alzheimer\u2019s disease and in the Gut-Brain axis. Microorganisms. https:\/\/doi.org\/10.3390\/MICROORGANISMS8020199","journal-title":"Microorganisms"},{"key":"4656_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES27010233","volume":"27","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Rahaman MS, Islam MR et al (2021) Role of phenolic compounds in human disease: current knowledge and future prospects. Molecules 27:233. https:\/\/doi.org\/10.3390\/MOLECULES27010233","journal-title":"Molecules"},{"key":"4656_CR125","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.YNSTR.2016.03.001","volume":"4","author":"K Rea","year":"2016","unstructured":"Rea K, Dinan TG, Cryan JF (2016) The microbiome: a key regulator of stress and neuroinflammation. Neurobiol Stress 4:23\u201333. https:\/\/doi.org\/10.1016\/J.YNSTR.2016.03.001","journal-title":"Neurobiol Stress"},{"key":"4656_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2023.12.007","author":"J Roach","year":"2024","unstructured":"Roach J, Mital R, Haffner JJ et al (2024) Microbiome metabolite quantification methods enabling insights into human health and disease. Methods. https:\/\/doi.org\/10.1016\/j.ymeth.2023.12.007","journal-title":"Methods"},{"key":"4656_CR127","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/risa.13316","volume":"39","author":"J Rodricks","year":"2019","unstructured":"Rodricks J, Huang Y, Mantus E, Shubat P (2019) Do interactions between environmental chemicals and the human microbiome need to be considered in risk assessments? Risk Anal 39:2353\u20132358. https:\/\/doi.org\/10.1111\/risa.13316","journal-title":"Risk Anal"},{"key":"4656_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.843170","author":"S Rosas-Plaza","year":"2022","unstructured":"Rosas-Plaza S, Hern\u00e1ndez-Ter\u00e1n A, Navarro-D\u00edaz M et al (2022) Human gut microbiome across different lifestyles: from hunter-gatherers to urban populations. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.843170","journal-title":"Front Microbiol"},{"key":"4656_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2023.1130689","volume":"14","author":"JA Rusch","year":"2023","unstructured":"Rusch JA, Layden BT, Dugas LR (2023) Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne) 14:1130689. https:\/\/doi.org\/10.3389\/FENDO.2023.1130689","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4656_CR130","doi-asserted-by":"publisher","unstructured":"Russo E, Giudici F, Fiorindi C et al (2019) Immunomodulating activity and therapeutic effects of short chain fatty acids and Tryptophan Post-biotics in inflammatory bowel disease. Front Immunol 10. https:\/\/doi.org\/10.3389\/FIMMU.2019.02754\/FULL","DOI":"10.3389\/FIMMU.2019.02754\/FULL"},{"key":"4656_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBR.2025.115789","volume":"495","author":"S Sal-Sarria","year":"2025","unstructured":"Sal-Sarria S, Burnet PWJ (2025) Early-life cognitive effects of prebiotics and probiotics: a cross-species systematic review. Behav Brain Res 495:115789. https:\/\/doi.org\/10.1016\/J.BBR.2025.115789","journal-title":"Behav Brain Res"},{"key":"4656_CR132","first-page":"1","volume":"36","author":"ME Sanders","year":"2007","unstructured":"Sanders ME, Gibson GR, Gill HS, Guarner F (2007) Probiotics: their potential to impact human health. Council Agric Sci Technol 36:1\u201320","journal-title":"Council Agric Sci Technol"},{"key":"4656_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/S10620-020-06133-5","volume":"65","author":"V Saurman","year":"2020","unstructured":"Saurman V, Margolis KG, Luna RA (2020) Autism spectrum disorder as a brain-gut-microbiome axis disorder. Dig Dis Sci 65:818. https:\/\/doi.org\/10.1007\/S10620-020-06133-5","journal-title":"Dig Dis Sci"},{"key":"4656_CR134","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/1040869059096","volume":"45","author":"A Scalbert","year":"2005","unstructured":"Scalbert A, Manach C, Morand C et al (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287\u2013306. https:\/\/doi.org\/10.1080\/1040869059096","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4656_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41398-022-01977-Z","volume":"12","author":"AC Schaub","year":"2022","unstructured":"Schaub AC, Schneider E, Vazquez-Castellanos JF et al (2022) Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry 12:1\u201310. https:\/\/doi.org\/10.1038\/S41398-022-01977-Z","journal-title":"Transl Psychiatry"},{"key":"4656_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-023-30909-0","volume":"13","author":"LM Schmitt","year":"2023","unstructured":"Schmitt LM, Smith EG, Pedapati EV et al (2023) Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Sci Rep 13:1\u201312. https:\/\/doi.org\/10.1038\/S41598-023-30909-0","journal-title":"Sci Rep"},{"key":"4656_CR137","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003","journal-title":"Neuropharmacology"},{"key":"4656_CR138","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"Seo Doh","year":"2024","unstructured":"Doh Seo, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56:86\u201394. https:\/\/doi.org\/10.1038\/s12276-023-01146-2","journal-title":"Exp Mol Med"},{"key":"4656_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/NU13051516","volume":"13","author":"R Shahbazi","year":"2021","unstructured":"Shahbazi R, Sharifzad F, Bagheri R et al (2021) Anti-inflammatory and immunomodulatory properties of fermented plant foods. Nutrients 13:1516. https:\/\/doi.org\/10.3390\/NU13051516","journal-title":"Nutrients"},{"key":"4656_CR140","doi-asserted-by":"publisher","unstructured":"Shanahan F, Ghosh TS, O\u2019Toole PW (2023) Human microbiome variance is underestimated. Curr Opin Microbiol. 2023;73:102288. https:\/\/doi.org\/10.1016\/j.mib.2023.102288","DOI":"10.1016\/j.mib.2023.102288"},{"key":"4656_CR141","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6658674","volume":"2021","author":"G Shen","year":"2021","unstructured":"Shen G, Wu J, Ye BC, Qi N (2021) Gut microbiota-derived metabolites in the development of diseases. Can J Infect Dis Med Microbiol 2021:6658674. https:\/\/doi.org\/10.1155\/2021\/6658674","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4656_CR142","doi-asserted-by":"publisher","first-page":"508738","DOI":"10.3389\/FENDO.2020.00025\/BIBTEX","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of Short-Chain fatty acids from gut microbiota in gut-Brain communication. Front Endocrinol (Lausanne) 11:508738. https:\/\/doi.org\/10.3389\/FENDO.2020.00025\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4656_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/NU11092216","volume":"11","author":"AK Singh","year":"2019","unstructured":"Singh AK, Cabral C, Kumar R et al (2019) Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency. Nutrients 11:2216. https:\/\/doi.org\/10.3390\/NU11092216","journal-title":"Nutrients"},{"key":"4656_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2021.105840","volume":"172","author":"K Soca\u0142a","year":"2021","unstructured":"Soca\u0142a K, Doboszewska U, Szopa A et al (2021) The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840. https:\/\/doi.org\/10.1016\/J.PHRS.2021.105840","journal-title":"Pharmacol Res"},{"key":"4656_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2023.1149618","volume":"14","author":"R Solanki","year":"2023","unstructured":"Solanki R, Karande A, Ranganathan P (2023) Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration. Front Neurol 14:1149618. https:\/\/doi.org\/10.3389\/FNEUR.2023.1149618","journal-title":"Front Neurol"},{"key":"4656_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS24032019","volume":"24","author":"V Sorrenti","year":"2023","unstructured":"Sorrenti V, Bur\u00f2 I, Consoli V, Vanella L (2023) Recent advances in health benefits of bioactive compounds from food wastes and by-products: biochemical aspects. Int J Mol Sci 24:2019. https:\/\/doi.org\/10.3390\/IJMS24032019","journal-title":"Int J Mol Sci"},{"key":"4656_CR147","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/BPH.12230","volume":"169","author":"TW Stone","year":"2013","unstructured":"Stone TW, Darlington LG (2013) The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol 169:1211\u20131227. https:\/\/doi.org\/10.1111\/BPH.12230","journal-title":"Br J Pharmacol"},{"key":"4656_CR148","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/J.NEUROPHARM.2016.02.030","volume":"112","author":"B Strasser","year":"2017","unstructured":"Strasser B, Becker K, Fuchs D, Gostner JM (2017) Kynurenine pathway metabolism and immune activation: peripheral measurements in psychiatric and co-morbid conditions. Neuropharmacology 112:286\u2013296. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2016.02.030","journal-title":"Neuropharmacology"},{"key":"4656_CR149","doi-asserted-by":"publisher","unstructured":"Sun W, Shahrajabian MH (2023) Therapeutic potential of phenolic compounds in medicinal plants\u2014Natural health products for human health. Molecules 28:1845. https:\/\/doi.org\/10.3390\/MOLECULES28041845","DOI":"10.3390\/MOLECULES28041845"},{"key":"4656_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2020.00156","volume":"11","author":"T Szeligowski","year":"2020","unstructured":"Szeligowski T, Yun AL, Lennox BR, Burnet PWJ (2020) The gut microbiome and schizophrenia: the current state of the field and clinical applications. Front Psychiatry 11:518742. https:\/\/doi.org\/10.3389\/FPSYT.2020.00156","journal-title":"Front Psychiatry"},{"issue":"8","key":"4656_CR151","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE (2022) The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic. Nat Rev Neurol 18(8):476\u2013495. https:\/\/doi.org\/10.1038\/s41582-022-00681-2","journal-title":"Nat Rev Neurol"},{"key":"4656_CR152","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S254403","volume":"13","author":"W Tang","year":"2020","unstructured":"Tang W, Zhu H, Feng Y et al (2020) The impact of gut microbiota disorders on the Blood\u2013Brain barrier. Infect Drug Resist 13:3351. https:\/\/doi.org\/10.2147\/IDR.S254403","journal-title":"Infect Drug Resist"},{"key":"4656_CR153","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823. https:\/\/doi.org\/10.1042\/BCJ20160510","journal-title":"Biochem J"},{"key":"4656_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/MICROORGANISMS10061121","volume":"10","author":"K Tsamakis","year":"2022","unstructured":"Tsamakis K, Galinaki S, Alevyzakis E et al (2022) Gut microbiome: a brief review on its role in schizophrenia and first episode of psychosis. Microorganisms 10:1121. https:\/\/doi.org\/10.3390\/MICROORGANISMS10061121","journal-title":"Microorganisms"},{"key":"4656_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S12602-024-10370-9","volume":"2024","author":"MA Tufail","year":"2024","unstructured":"Tufail MA, Schmitz RA (2024) Exploring the probiotic potential of bacteroides spp. Within one health paradigm. Probiotics Antimicrob Proteins 2024:1\u201324. https:\/\/doi.org\/10.1007\/S12602-024-10370-9","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"4656_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41467-019-08294-Y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, Frye AK, El-Gendy AO et al (2019) Gut bacterial tyrosine decarboxylases restrict levels of Levodopa in the treatment of parkinson\u2019s disease. Nat Commun 10(1):1\u201311. https:\/\/doi.org\/10.1038\/S41467-019-08294-Y","journal-title":"Nat Commun"},{"key":"4656_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS232012289","author":"A Varesi","year":"2022","unstructured":"Varesi A, Campagnoli LIM, Fahmideh F et al (2022) The interplay between gut microbiota and Parkinson\u2019s disease: implications on diagnosis and treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS232012289","journal-title":"Int J Mol Sci"},{"key":"4656_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171436","volume":"13","author":"A Verma","year":"2024","unstructured":"Verma A, Inslicht SS, Bhargava A (2024) Gut-brain axis: role of microbiome, metabolomics, hormones, and stress in mental health disorders. Cells 13:1436. https:\/\/doi.org\/10.3390\/cells13171436","journal-title":"Cells"},{"key":"4656_CR159","doi-asserted-by":"publisher","first-page":"106337","DOI":"10.1016\/J.JFF.2024.106337","volume":"119","author":"O Victoria Obayomi","year":"2024","unstructured":"Victoria Obayomi O, Folakemi Olaniran A, Olugbemiga Owa S (2024) Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: A review. J Funct Foods 119:106337. https:\/\/doi.org\/10.1016\/J.JFF.2024.106337","journal-title":"J Funct Foods"},{"key":"4656_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA et al (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"key":"4656_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03340-9","volume":"60","author":"S Wang","year":"2023","unstructured":"Wang S, Xu C, Liu H et al (2023a) Connecting the gut microbiota and neurodegenerative diseases: the role of bile acids. Mol Neurobiol 60:4618\u20134640. https:\/\/doi.org\/10.1007\/s12035-023-03340-9","journal-title":"Mol Neurobiol"},{"key":"4656_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01656-1","author":"T Wang","year":"2023","unstructured":"Wang T, Chen B, Luo M et al (2023b) Microbiota-indole 3-propionic acid-brain axis mediates abnormal synaptic pruning of hippocampal microglia and susceptibility to ASD in IUGR offspring. Microbiome. https:\/\/doi.org\/10.1186\/s40168-023-01656-1","journal-title":"Microbiome"},{"key":"4656_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01635-6","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou J, Ye J et al (2023) Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder. Microbiome. https:\/\/doi.org\/10.1186\/s40168-023-01635-6","journal-title":"Microbiome"},{"key":"4656_CR164","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/070674370404900208","volume":"49","author":"P Waraich","year":"2004","unstructured":"Waraich P, Goldner EM, Somers JM, Hsu L (2004) Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 49:124\u2013138. https:\/\/doi.org\/10.1177\/070674370404900208","journal-title":"Can J Psychiatry"},{"issue":"8","key":"4656_CR165","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","volume":"69","author":"RK Weersma","year":"2020","unstructured":"Weersma RK, Zhernakova A, Fu J (2020) Interaction between drugs and the gut Microbiome. 69(8):1510\u20131519 https:\/\/doi.org\/10.1136\/gutjnl-2019-320204","journal-title":"Gut"},{"key":"4656_CR166","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/BS.PMBTS.2019.06.013","volume":"168","author":"S Westfall","year":"2019","unstructured":"Westfall S, Iqbal U, Sebastian M, Pasinetti GM (2019) Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of alzheimer\u2019s disease. Prog Mol Biol Transl Sci 168:147\u2013181. https:\/\/doi.org\/10.1016\/BS.PMBTS.2019.06.013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4656_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/NU15143258","volume":"15","author":"RG Xiong","year":"2023","unstructured":"Xiong RG, Li J, Cheng J et al (2023) The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients 15:3258. https:\/\/doi.org\/10.3390\/NU15143258","journal-title":"Nutrients"},{"key":"4656_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914756","volume":"24","author":"SK Yadav","year":"2023","unstructured":"Yadav SK, Ito K, Dhib-Jalbut S (2023) Interaction of the gut microbiome and immunity in multiple sclerosis: impact of diet and immune therapy. Int J Mol Sci 24:14756. https:\/\/doi.org\/10.3390\/ijms241914756","journal-title":"Int J Mol Sci"},{"key":"4656_CR169","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5288698","author":"L Yan","year":"2022","unstructured":"Yan L, Guo MS, Zhang Y et al (2022) Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/5288698","journal-title":"Oxid Med Cell Longev"},{"key":"4656_CR170","doi-asserted-by":"publisher","first-page":"1206468","DOI":"10.3389\/FNUT.2023.1206468\/FULL","volume":"10","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhou B, Zhang S et al (2023) Prebiotics for depression: how does the gut microbiota play a role? Front Nutr 10:1206468. https:\/\/doi.org\/10.3389\/FNUT.2023.1206468\/FULL","journal-title":"Front Nutr"},{"key":"4656_CR171","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70091","author":"J Yang","year":"2024","unstructured":"Yang J, Liang J, Hu N et al (2024) The gut microbiota modulates neuroinflammation in Alzheimer\u2019s disease: elucidating crucial factors and mechanistic underpinnings. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/cns.70091","journal-title":"CNS Neurosci Ther"},{"key":"4656_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/BRB3.70401","volume":"15","author":"A Zandifar","year":"2025","unstructured":"Zandifar A, Badrfam R, Mohammaditabar M et al (2025) The effect of prebiotics and probiotics on levels of depression, anxiety, and cognitive function: a meta-analysis of randomized clinical trials. Brain Behav 15:e70401. https:\/\/doi.org\/10.1002\/BRB3.70401","journal-title":"Brain Behav"},{"key":"4656_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19327-w","author":"I Zarei","year":"2022","unstructured":"Zarei I, Koistinen VM, Kokla M et al (2022) Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-19327-w","journal-title":"Sci Rep"},{"key":"4656_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/NU14245373","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yu W, Zhang L et al (2022) The interaction of polyphenols and the gut microbiota in neurodegenerative diseases. Nutrients. https:\/\/doi.org\/10.3390\/NU14245373","journal-title":"Nutrients"},{"key":"4656_CR175","doi-asserted-by":"publisher","unstructured":"Zhang D, Jian YP, Zhang YN et al (2023) Short-chain fatty acids in diseases. Cell Commun Signal 21:1\u201320. https:\/\/doi.org\/10.1186\/S12964-023-01219-9","DOI":"10.1186\/S12964-023-01219-9"},{"issue":"1","key":"4656_CR176","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Chen Y, Huang W et al (2023) Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther 8(1):386 https:\/\/doi.org\/10.1038\/s41392-023-01619-w","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4656_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-024-78463-7","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang H, Huo P et al (2024) The association between circulating short-chain fatty acids and blood pressure in Chinese elderly population. Sci Rep 14(1):1\u201311. https:\/\/doi.org\/10.1038\/S41598-024-78463-7","journal-title":"Sci Rep"},{"key":"4656_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y et al (2022) Gut microbiota: a novel therapeutic target for parkinson\u2019s disease. Front Immunol 13:937555. https:\/\/doi.org\/10.3389\/FIMMU.2022.937555","journal-title":"Front Immunol"},{"key":"4656_CR179","doi-asserted-by":"publisher","unstructured":"Gupta MK, Srivastava R. Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management. Probiotics Antimicrob Proteins. 2025;17(4):2629-2652. doi:10.1007\/s12602-025-10582-7 https:\/\/doi.org\/10.1007\/s12602-025-10582-7","DOI":"10.1007\/s12602-025-10582-7"},{"key":"4656_CR180","doi-asserted-by":"publisher","unstructured":"Gupta MK, Chauhan K, Bhardwaj S, Srivastava R. Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment. Probiotics Antimicrob Proteins. Published online June 27, 2025. doi: 10.1007\/s12602-025-10632-0 https:\/\/doi.org\/10.1007\/s12602-025-10632-0","DOI":"10.1007\/s12602-025-10632-0"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04656-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-025-04656-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-025-04656-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:04:59Z","timestamp":1764180299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-025-04656-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":180,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4656"],"URL":"https:\/\/doi.org\/10.1007\/s11274-025-04656-5","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}